Mimedx (MDXG) EBIT Margin Growth (5y) (2016 - 2026)
Powered by 
Analysis
Mimedx (MDXG) EBIT Margin Growth (5y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.92 Bn | 176.31 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.64 Bn | 122.42 Bn | 1.96 Bn |
| 3 | Medtronic | 117.92 Bn | 109.10 Bn | 6.34 Bn |
| 4 | Stryker | 105.39 Bn | 101.91 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.88 Bn | 64.34 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.66 Bn | 1.35 Bn |
| 7 | Alcon | 33.24 Bn | 31.79 Bn | 1.68 Bn |
| 8 | Dexcom | 32.12 Bn | 30.18 Bn | 830.00 Mn |
| 9 | Steris | 20.83 Bn | 20.35 Bn | 684.20 Mn |
| 10 | Mimedx | 683.56 Mn | 547.72 Mn | 44.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,809.00 |
| Mar 31, 2026 | -1,578.00 |
| Dec 31, 2025 | 4,132.00 |
| Sep 30, 2025 | 3,461.00 |
| Jun 30, 2025 | 2,346.00 |
| Mar 31, 2025 | 3,162.00 |
| Dec 31, 2024 | 1,827.00 |
| Sep 30, 2024 | -270.00 |
| Jun 30, 2024 | 5,221.00 |
| Mar 31, 2024 | 3,573.00 |
| Dec 31, 2023 | 2,750.00 |
| Sep 30, 2023 | 1,318.00 |
| Jun 30, 2023 | 1,158.00 |
| Mar 31, 2023 | -400.00 |
| Dec 31, 2022 | -1,209.00 |
| Sep 30, 2022 | -2,102.00 |
| Jun 30, 2022 | -2,337.00 |
| Mar 31, 2022 | -2,478.00 |
| Dec 31, 2021 | 1,519.00 |
| Sep 30, 2021 | -900.00 |